The specific, sensitive and reliable detection of mycoplasma contamination in cell cultures is an important part of mycoplasma control. We have sought to develop and validate a method for mycoplasma detection which is sensitive and accurate, but also practical in the sense of time spent, costs, and applicability in the standard laboratory; finally, the method should be suitable for screening large numbers of test specimens. To that end, we adapted a previously developed polymerase chain reaction (PCR) method for daily routine application. This single-step PCR uses a mixture of primers annealing to gene sequences coding for evolutionarily conserved 16S rRNA of different mycoplasma species, including the ones most commonly found in cell cultures. An internal control was introduced to exclude any false-negative tests resulting from technical PCR problems. This mycoplasma detection by PCR has been validated prospectively on 201 consecutive leukemia-lymphoma cell lines received at the institute over a 3-year period and on 118 initially positive cell lines after anti-mycoplasma treatment with antibiotics. The sensitivity (detection of true positives) of this PCR detection assay was 96% and the specificity (detection of true negatives) was also 96%, with positive and negative predictive values (probability of correct result) of 86% and 99%, respectively. PCR defined the mycoplasma status with 96% accuracy (detection of true positives and true negatives). Besides the high sensitivity and specificity, further attractive features of the PCR approach are the ease and speed with which large numbers of specimens can be tested. PCR mycoplasma analysis provides a readily available, quick and reliable test system with which to manage the important issue of mycoplasma contamination of cell lines.
Introduction
A large variety of techniques for the detection of mycoplasma contamination of cell cultures have been described (reviewed in Ref. 1). Many of these methods are lengthy, complex and subjective and some of them appear to be only marginally useful. 2, 3 Prior to the era of molecular biology, the microbiological approach of incubating cell culture supernatant in specific broths and subsequent plating out on agar plates (with the ensuing typical 'fried egg-type' colonies) represented the 'gold standard' of mycoplasma detection and is still the refer- ence method in good manufacturing practice protocols and in pharmacopeias. However, this method also has its drawbacks (long incubation time and subjective interpretation of the results), in particular, as some mycoplasma strains will not always grow on agar.
Ideal mycoplasma detection methods should be highly sensitive and specific, but also simple, rapid, efficient, and cost effective. The evaluation of tests comprises the components' validity and reproducibility pertaining to the statistical parameters (operating characteristics): sensitivity (detection of true positives), specificity (detection of true negatives), accuracy (detection of true positives and true negatives -a combination of sensitivity and specificity), and predictive value (probability of correct result). Further aspects of the evaluation of a test are technical reproducibility and interobserver reproducibility (concordance of interpretation of the results). Most detection methods rely on subjective reading and interpretation of the results, which obviously requires training, experience, and consensus. 2 The 'new era' of mycoplasma detection began in the 1980s with the introduction of molecular biological tests which are based on the development of gene or DNA probes. The principle is simple as genes or genomic sequences that are specific for a single species or a particular group of mycoplasma or globally for nearly all mycoplasmas are identified and synthesized; these probes are then employed for DNA or RNA hybridization. The more recent development of polymerase chain reaction (PCR) enables the amplification of the target DNA in the specimen using specific synthetic oligonucleotides complementary to conserved rDNA sequences and increases the sensitivity by several orders of magnitude. 4 Positive hybridization signals as dots on filters or scintillation counts and visual demonstration of the PCR amplicon in gels indicate the presence of the infectious agent.
Here, we evaluated prospectively the performance of a PCR assay for the examination of the mycoplasma status of a large panel of consecutively received leukemia-lymphoma (LL) cell lines. As the use of cell lines as in vitro model systems is still increasing and taking the large percentage of infected cell cultures into account (Figure 1 ), a quick, robust and reliable diagnostic molecular screen such as PCR will become very useful for frequent monitoring of cell cultures for mycoplasma contaminations. 
Materials and methods

Cultivation of cell lines
All cell cultures examined in this study were continuous human LL cell lines that were received consecutively at the institute either for accessioning to the cell lines bank or for research purposes. 5, 6 All cell lines were grown at 37°C in a humidified atmosphere of air containing 5% CO 2 . The basic growth media (Gibco BRL Life Technologies, Karlsruhe, Germany) were supplemented with 5-20% fetal bovine serum (FBS; Sigma, Deisenhofen, Germany). For factor-dependent cell lines, specific growth factors or conditioned media containing growth factors were added. For mycoplasma detection, the cell lines were cultured for at least 1 week after thawing and samples were taken after a culture period of at least 2 days without medium exchange. Except specifically for the elimination of mycoplasma, no antibiotics were added to the cultures.
Anti-mycoplasma antibiotic treatment
Mycoplasma-positive cell lines were treated with specific antimycoplasma antibiotics as described in detail in the accompanying article. 
Microbiological agar culture
Media for the detection of mycoplasma colonies by microbiological culture were prepared according to the previously described method. 2 Cell culture supernatants (200 l) were incubated in two different broth liquid media (Friis medium and PH medium) at 37°C; after 3-5 days, aliquots were pipetted on to the respective agar plates. Development of typical colonies ('fried egg appearance') was observed under the inverted microscope.
Friis broth medium: solution I (0.82 g Bacto brain heart infusion (Difco, Hamburg, Germany), 0.87 g Bacto PPLO broth (Difco) in 50 ml Hank's balanced salt solution (BSS), PH broth medium: 0.84 g Bacto PPLO broth in 40 ml H 2 O, to pH 6.5 with 1 m HCl; autoclaving was followed by the addition of 10 ml KNB solution (100 ml heat-inactivated horse serum (Gibco BRL), 5 ml yeast extract solution, 1 ml 0.4% DNA solution (Difco), 1 ml H 2 O, to pH 7.8 with 5 m NaOH). PH agar medium: 3.5 g Bacto PPLO agar (Difco) in 100 ml H 2 O, to pH 6.5 with 1 m HCl; autoclaving was followed by the addition of 25 ml KNB solution (at 60°C).
Aliquots of 2 ml broth were frozen at −20°C. Ten ml of agar media were poured into 5 cm Petri dishes and stored at 4°C.
DNA-RNA hybridization assay
The assay detects specifically rRNA sequences of a large panel of mycoplasma species including those commonly seen in infected cultures. This assay was shown to be very reliable. 2 
A
3 H-labeled single-stranded DNA probe complementary to unspecified sequences of the 16S and 23S mycoplasmal rRNA is contained within the commercially available assay termed 'Gen-Probe' (Gen-Probe, San Diego, CA, USA). The cell culture supernatant was centrifuged at 300 g and the resulting supernatant was pelleted by high speed centrifugation at 15 000 g. These pellets were incubated with the radioactive probe for nucleic acid hybridization in solution at 72°C. To increase the sensitivity of the assay, the hybridization period was extended from the recommended 3 h to 18 h. Following separation of labeled DNA-RNA hybrids from the nonhybridized DNA probe with hydroxyapatite, washing and the addition of scintillation fluid, the results were quantified in a ␤-scintillation counter.
Polymerase chain reaction
A previously described PCR method was used in a modified version. 8 Cell culture supernatants (1 ml) were centrifuged for 6 min at 13 000 g. The resulting supernatants were discarded and the pellets were washed twice with phosphate-buffered saline (PBS). After the second wash, the pellets were resuspended in 100 l PBS and incubated for 15 min at 95°C. The DNAs were extracted with 'Wizard DNA Clean-Up System' (Promega, Mannheim, Germany) according to the instructions of the manufacturer (the DNAs were eluted from the column with 50 l dH 2 O at 80°C). One l of the solution was applied for the PCR amplification. The PCR was carried out in a final volume of 25 l in 1 × PCR buffer (Qiagen, Hilden, Germany) containing 1.5 mm MgCl 2 , 100 m dNTPs (each), 0.2 m of each oligonucleotide (Table 1) , 1 l internal control DNA, and 1.25 U Taq DNA polymerase (Qiagen). To perform a hot start PCR, 15 l of the reaction solution (but without the Taq polymerase) were mixed, denatured at 95°C for 7 min, and Table 1 Oligonucleotides used for amplification of 16S rDNA of different mycoplasma species 5′ primers 3′ primers cgc ctg agt agt acg ttc gc gcg gtg tgt aca aga ccc ga cgc ctg agt agt acg tac gc gcg gtg tgt aca aaa ccc ga tgc ctg agt agt aca ttc gc gcg gtg tgt aca aac ccc ga tgc ctg ggt agt aca ttc gc cgc ctg ggt agt aca ttc gc cgc ctg agt agt atg ctc gc Only three 3′ primers were used due to the higher conservation of this 16S rDNA region of the genus Mycoplasma. The mycoplasma species which are covered by these primers are listed in Refs 8 and 9.
cooled to 72°C; at this temperature, the Taq polymerase in 1 × PCR buffer was added. The first annealing step was carried out for 2 min at 65°C and the subsequent amplification step for 10 min at 72°C. After this initial cycle, 32 cycles of 95°C for 4 s, 65°C for 8 s, and 72°C for 16 s were run on the Applied Biosystems GeneAmp PCR System 9700 (Perkin Elmer Applied Biosystems, Weiterstadt, Germany). Ten l of the reaction mix were loaded on a 1.4% agarose gel. Depending on the mycoplasma species, the amplification product is 510-520 bp long.
The internal control was prepared by cloning the PCR amplification product of Acholeplasma laidlawii into the pGEM-T vector (Stratagene, Amsterdam, The Netherlands) and amplified in E. coli. Using SfuI, the resulting plasmid pMyco-GEM-T was linearized and a 476 bp TaqI fragment from pHMSE-1 10 was ligated into the SfuI site. Using this plasmid, a 986 bp fragment is competitively amplified in the PCR in the case that A. laidlawii is the contaminating mycoplasma species and non-competitively when other mycoplasma species are present in the cell cultures. The internal control DNA was added in a limiting dilution.
Statistical evaluation
Using the agar colony formation and the liquid DNA-RNA hybridization ('Gen-Probe') assays as the reference tests, the following statistical parameters (operating characteristics) were calculated from the set of available data. Sensitivity: true positives/true positives + false negatives; specificity: true negatives/true negatives + false positives; predictive value of a positive result and of a negative result: true positives/true positives + false positives and true negatives/true negatives + false negatives; accuracy: true positives + true negatives/total number of cases.
Results
Mycoplasma detection by PCR amplification
Several years ago, we developed a Mycoplasma genusspecific PCR detection method. 8 We have adapted our original procedure for the daily routine application by modifying three PCR-related parameters and by newly including an important feature. (1) In preliminary tests, the initially used nested two-step PCR assay produced too many false-positive data. In the daily routine, the nested PCR was too susceptible to contaminations due to the high number of samples tested Leukemia and the occasionally high amounts of amplified mycoplasmaspecific DNA handled. Dilution experiments showed that a single-step PCR was clearly sufficient to detect even low levels of contamination in cell cultures. Hence, we here applied only a single-round PCR. On the other hand, nested PCR should still be applied to test cell culture additives which were prepared from animals (such as FBS) where the mycoplasma titer may be extremely low. (2) While the PCR temperatures during the various cycle parts and the number of cycles were kept constant, we significantly shortened the denaturation (from 30 s to 4 s), the annealing (from 30 s to 8 s), and the amplification times (from 60 s to 16 s). These changes provided superior results, presumably as the Taq polymerase was not exhausted or destroyed. (3) We now purify mycoplasma DNA on a spin column because the internal control DNA showed that crude samples heated to 95°C and treated with proteinase K sometimes contained inhibitory substances and several dilutions were previously necessary to overcome this problem. (4) We included an internal PCR control (see Materials and methods), in order to verify that any negative result was not due to a methodological failure of PCR amplification. A representative example of a set of PCR amplifications, illustrating various mycoplasma-negative and -positive cell lines, is shown in Figure 2 .
Comparison with reference detection methods
In a prospective study over a 3-year period, we examined the mycoplasma status of 201 consecutive LL cell lines received at the institute, using in parallel PCR, a liquid DNA-RNA hybridization assay and colony formation on agar. In addition, the mycoplasma status of 118 initially mycoplasma-positive cell cultures was tested after treatment with anti-mycoplasma antibiotics. The DNA-RNA hybridization and agar assays were used here for the purpose of reference.
The three mycoplasma tests gave overall concordant results in 305 instances (240 mycoplasma-negative and 65 -positive cultures) ( Table 2 ). Among the 14 discordant results, only three appear to be 'false-negative' whereas 11 were considered to be 'false-positive'. Nine of these 11 discordant PCR-
Figure 2
PCR analysis of mycoplasma status in cell lines. Shown is an ethidium bromide-stained gel containing the reaction products following PCR amplification with the primer mix listed in Table 1 . Products of about 500 bp were obtained, the differences in length reflect the sequence variation between different mycoplasma species. Shown are various examples of mycoplasma-negative and -positive cell lines. Two paired PCR reactions were performed: one PCR reaction contained an aliquot of the sample only (a) and the second reaction contained the sample under study plus the control DNA as internal standard (b) (indicated by rule). a Concordant/discordant PCR results refer to the concordance/discordance with the two other mycoplasma detection assays employed here for comparison (DNA-RNA hybridization and agar colony formation). Operatively, 'discordant negative/ positive' results are considered here as 'false-negative/positive'; however, neither of the two reference assays can be considered as the absolute 'gold standard' of mycoplasma detection as these methods may occasionally produce false data (for a detailed discussion see Refs 1-3). b Mycoplasma-positive cell lines were treated with anti-mycoplasma antibiotics as outlined in Ref. 7 . c Number of cell lines.
positive cultures were detected shortly after treatment of mycoplasma positivity with antibiotics. However, upon further culturing of these treated cultures, the mycoplasma PCR also became negative in the retesting at a later time point post treatment. We presume that residual mycoplasma DNA without any viable mycoplasma cells might still be attached to the eukaryotic cells.
Taking all data together, the following statistical evaluation emerges: the specificity and sensitivity of PCR mycoplasma detection are each 96% with positive and negative predictive values of 86% and 99%, respectively. PCR defines the mycoplasma status with 96% accuracy (Table 2 ).
Discussion
The PCR technology which is now used for an enormous number of analytic and diagnostic applications, was also adapted to identify mycoplasma contamination of cell cultures (reviewed in Ref. 11 ). This method encompasses several features which render it a very competitive and reliable tool. PCR is a very sensitive, specific, relatively simple, inexpensive and rapid procedure to detect distinctive DNA sequences.
The first reports on the application of PCR to diagnose mycoplasma infection appeared in 1989. 1 There are principally three variations of PCR-based mycoplasma detection: (1) detection of any mycoplasma infection (genus-specific PCR); (2) detection of single mycoplasma species (species-specific PCR); and (3) identification of the mycoplasma species with species-specific PCR or genus-specific PCR followed by sequencing of the PCR product or restriction fragment length polymorphism analysis (reviewed in Ref. 11) .
We focused on the genus-specific PCR using a mixture of primers which will react with DNA of any mycoplasma. 'Universal primers' hybridizing to the most conserved regions of the rDNA are capable of additionally detecting bacteria other than mycoplasma. However, this alleged advantage is offset by the risk of false-positive results due to bacterial contaminations of the reagents or during set-up of the PCR reaction. Since 'common bacterial' contaminations are easily detected during routine cell culture, a restriction to mycoplasmas in the PCR assay appears to be more recommendable. Speciesspecific PCRs are commonly applied for selective medical examinations and not for the routine detection of mycoplasmas in cell cultures. It appears to be satisfactory to use a genus-specific PCR approach for the detection of mycoplasma cell culture infection where the primary goal is just to screen the cultures for contamination and not to specify the contaminant.
Recently, we selected genus-specific primers and developed a powerful PCR mycoplasma detection assay 8 (see also Ref. 11 for a discussion of primer selection). Here, we modified this assay slightly and adapted it for daily routine use. In order to validate the assay, our efforts were therefore directed towards assessing the ease and speed of the PCR mycoplasma analysis and its sensitivity, specificity, accuracy and reliability for determining the mycoplasma status of cell lines.
Instead of the originally proposed two-step (nested) PCR, we employed a single-step PCR. While it is generally assumed that the nested PCR approach considerably increases the sensitivity and specificity of the assay, it also increases the risk of contamination by DNA carryover. Southern blotting of PCR products and hybridization with a specific radiolabeled internal probe is another possibility to enhance sensitivity. The detection limit using a set of nested universal primers had been described to be 1 fg mycoplasmal DNA, which is equivalent to one to two genome copies of the 16S rRNA coding region (mollicute genomes carry only one or two rRNA gene sets). However, in our experience such an extremely high level of sensitivity is usually not required in routine diagnosis as acute and particularly chronic cell culture infections involve a large number of organisms (commonly 10 6 or higher per ml). In our hands, the single-step PCR was definitely sufficient for the purpose of a diagnostic mycoplasma detection assay. Also, the application of RT-PCR used for the detection of the abundant 16S rRNA molecules does not appear to be necessary in the routine setting. During our preliminary testing phase applying the nested PCR, we encountered a number of clearly false-positive results. The possible problem of falsenegative data due to inhibition of the Taq polymerase or other technical errors was addressed by including an internal control in every sample under study in a second parallel tube.
Our prospective evaluation of PCR for mycoplasma detection in a routine setting gave excellent scores in the categories sensitivity, specificity, predictive value, and accuracy as assessed in comparison with two standard mycoplasma detection methods. Nine out of eleven false-positive cases concerned samples which were taken several days post treatment with anti-mycoplasma antibiotics. Hence, this represents a unique situation and the false-positive results might be caused not by resistant viable mycoplasma cells but by residual mycoplasmal DNA which is attached to eukaroytic cells. This problem can be overcome by further passaging and repeated washings of the eukaryotic cells with mycoplasma-free medium.
As the mycoplasma detection PCR can be also done with frozen and lyophilized material, this offers a means for a retrospective analysis and facilitates the transport, collection, and storage of samples. In preliminary experiments, we did not encounter any significant differences between freshly taken and frozen stored samples with regard to mycoplasma detec-tion. A final mycoplasma PCR result using the method presented here may be obtained within 4.5 h (time from sample collection to documentation of amplicons on an ethidium bromide-stained gel), including about 1 h of sample preparation and PCR reaction. As in other applications, PCR also offers a high throughput of samples. Excluding one-off expenditures for various apparatus (eg thermal cycler, gel electrophoresis system, imaging system) and oligonucleotides, the costs per mycoplasma PCR assay are in the range of 1-2 US$.
PCR appears to be clearly superior to other mycoplasma detection methods in many respects as this approach combines simplicity and speed with high specificity and sensitivity, in addition to objectivity, accuracy and reproducibility. 1, 8, 11 In particular, PCR is not limited by the ability of an organism to grow in culture; in certain areas, this molecular nucleic acid amplification may eventually replace biological amplification (ie growth in artificial media), a feature of paramount importance considering the fastidious nature of some mycoplasma species. 4 Thus, given the high percentage of mycoplasma-contaminated cell lines (Figure 1 ) and the need for a simple and practical test, PCR should prove to be the state of the art technique for mycoplasma detection in cell cultures.
In summary, this large prospective study establishes PCR as an excellent tool for routine mycoplasma status evaluation of cell cultures which should be done at regular intervals. 1 In the situation of mycoplasma eradication with antibiotics, confirmational serial PCR is recommended to exclude false-positive results post treatment.
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